Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_assertion description "[The results show that combination immunotherapy consisting of vaccination with a synthetic peptide corresponding to an immunodominant CTL epitope derived from tyrosinase-related protein-2 administered with CpG-ODN adjuvant and followed by systemic injection of anti-CTLA-4 antibodies increased the survival of mice against the poorly immunogenic B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_assertion evidence source_evidence_literature NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_assertion SIO_000772 12810660 NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_assertion wasDerivedFrom befree-20150227 NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_assertion wasGeneratedBy ECO_0000203 NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP350556.RAG132VleIQx4qkagMld8MfrFviLLEF6wfUu0pWf9Y2zA130_provenance.